Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 109,632,268
- Share change
- +15,016,329
- Total reported value
- $1,377,359,505
- Put/Call ratio
- 102%
- Price per share
- $12.57
- Number of holders
- 222
- Value change
- +$161,902,372
- Number of buys
- 140
- Number of sells
- 68
Report period
Q4 2024
Institutions
222
Top holders
10
RCKT full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
18,037,772
mixed-class rows
|
$326,715,724 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
10%
|
11,242,144
|
$207,642,399 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.8%
|
6,370,721
|
$117,667,217 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.1%
|
5,536,940
|
$102,267,282 | — | 30 Sep 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
4.1%
|
4,493,833
|
$83,001,096 | — | 30 Sep 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.8%
|
4,118,672
|
$76,071,872 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
3,207,781
|
$59,248,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
3,102,022
|
$57,294,346 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
2,491,490
mixed-class rows
|
$39,699,316 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.7%
|
1,897,340
|
$35,055,215 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,617,866
|
$29,887,855 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.6%
|
1,730,344
|
$29,242,814 | — | 30 Sep 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
1,485,630
|
$27,439,586 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$27,077,962 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.3%
|
1,386,705
|
$25,612,441 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,202,495
|
$22,210,083 | — | 30 Sep 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1%
|
1,100,000
|
$20,317,000 | — | 30 Sep 2024 | |
| Novo Holdings A/S |
13F
|
Company |
1%
|
1,100,000
|
$20,317,000 | — | 30 Sep 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.98%
|
1,066,373
|
$19,695,909 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.85%
|
931,851
|
$17,211,288 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.84%
|
912,605
|
$16,855,671 | — | 30 Sep 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.81%
|
884,341
|
$16,333,778 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.74%
|
812,310
|
$15,003,371 | — | 30 Sep 2024 | |
| COMERICA BANK |
13F
|
Company |
0.72%
|
785,526
|
$14,508,669 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
770,691
|
$14,234,663 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
750,000
|
$13,852,500 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.69%
|
749,000
|
$13,834,030 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.57%
|
621,306
|
$11,475,522 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.56%
|
615,528
|
$11,368,802 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.55%
|
601,063
|
$11,101,634 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
580,836
|
$10,728,041 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.52%
|
569,814
|
$10,524,465 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.51%
|
556,552
|
$10,279,515 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.43%
|
465,456
|
$8,596,979 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
424,073
|
$7,832,611 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
406,259
mixed-class rows
|
$7,501,763 | — | 30 Sep 2024 | |
| M28 Capital Management LP |
13F
|
Company |
0.35%
|
385,680
|
$7,123,510 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
352,622
|
$6,512,928 | — | 30 Sep 2024 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.32%
|
347,625
|
$6,420,634 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.31%
|
338,134
|
$6,245,335 | — | 30 Sep 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.3%
|
325,000
|
$6,002,750 | — | 30 Sep 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.27%
|
294,800
|
$5,444,956 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.27%
|
291,106
|
$5,376,728 | — | 30 Sep 2024 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
285,665
|
$5,273,376 | — | 30 Sep 2024 | |
| EFG Asset Management (North America) Corp. |
13F
|
Company |
0.22%
|
244,420
|
$4,518,104 | — | 30 Sep 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.22%
|
235,004
|
$4,338,174 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.21%
|
231,792
|
$4,281,198 | — | 30 Sep 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.2%
|
221,046
|
$4,082,720 | — | 30 Sep 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.18%
|
197,096
|
$3,640,363 | — | 30 Sep 2024 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.17%
|
190,000
|
$3,509,300 | — | 30 Sep 2024 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q4 2024
As of 31 Dec 2024,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,632,268 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., VANGUARD GROUP INC, MAVERICK CAPITAL LTD, WESTFIELD CAPITAL MANAGEMENT CO LP, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
223
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
189
Q4 2024 holders
222
Holder diff
33
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.